<!doctype html>
<html lang="en">
    <head>
        <meta charset="utf-8"/>
        <meta name="viewport" content="width=device-width,initial-scale=1,user-scalable=no"/>
        <meta name="format-detection" content="telephone=no"/>
        <meta name="apple-mobile-web-app-capable" content="yes"/>
        <meta name="apple-mobile-web-app-status-bar-style" content="black"/>
        <title><!-- Key Message Description --></title>
        <link rel="stylesheet" href="../shared/shared-dificid-v4/js/ext/avModal/themes/default.css"/>
        <link rel="stylesheet" href="../shared/shared-dificid-v4/css/shared-main.css"/>
        <link rel="stylesheet" href="css/specific.css"/>
    </head>
    <body data-pix="true" data-SlideName="Introduction">
    	<section id="wrapper">
            <!-- Landscape Header with Tracking -->
    		<header class="landscapeHeader">
            <div class="homeIcon" data-slide="0.0_dificid_v4_home.zip">&nbsp;</div>
                <div class="halfMoon" id="halfMoonTOC">&nbsp;</div>      
            </header>
           
    		<section id="contentWrapper">
    			<div id="content"> <!--====== main content Starts ========--> 
                    <!-- Navigation Starts-->
                    <nav data-count="six">&nbsp;</nav>
                    <!-- Navigation Ends --> 
                    <!-- Landscape Start -->
                    <div id="landscape">
                        <!-- Slide Specific Code Start -->
                        <section>
                            <div class="upperBorder"></div>
                            <div class="introContainer">
                                <div class="introTitle darkGreen light fs29 lh35">
                                    Which treatment strategy for CDI is most<br/>
                                        <div class="introTitleSecondLine">cost-effective?</div>
                                </div>
                                <div class="titleContentFirst darkGreen fs18 bold">
                                    <p>Determining the answer</p>
                                </div>
                                <div class="contentFirst fs14 lh18">
                                    In 2018, the Infectious Diseases Society of America (IDSA) published updated guidelines for<br/>
                                        the diagnosis and treatment of <em>Clostridium difficile</em> infection (CDI)
                                </div>
                                <div class="containerQuoteOne">
                                    <div class="greenLineOne"></div>
                                    <div class="quoteOne darkGreen fs16 light lh22">
                                        No guidance exists on which guideline-recommended treatment<br/>
                                            is most cost-effective
                                    </div>
                                    <div class="greenLineTwo"></div>
                                </div>
                                <div class="contentAfterQuoteOne fs14">
                                        Rajasingham et al. conducted an evaluation of the cost-effectiveness of recommended<br/>
                                        treatment regimens
                                </div>
                                <div class="containerQuoteTwo">
                                        <div class="greenLineThree"></div>
                                        <div class="quoteTwo darkGreen fs16 light">
                                        Study simulated a cohort of patients presenting with initial CDI
                                        </div>
                                        <div class="greenLineFour"></div>
                                 </div>
                                 <div class="contentSecond">
                                        <div class="contentTitleSecond darkGreen fs18 bold">
                                            Independently funded
                                        </div>
                                        <div class="contentListSecond">
                                            <ul class="fs14">
                                                <li>
                                                    This work was supported by the National Institutes of Health [K23AI13885 to RR;<br/>
                                                    <div class="lstOne">K25AI118476 to EE] </div> 
                                                </li>
                                            </ul>
                                        </div>
                                    </div>
                                    <div class="contentThird">
                                            <div class="contentTitleThird darkGreen fs18 bold">
                                                    No Merck conflicts of interest
                                            </div>
                                            <div class="contentListThird">
                                                <ul class="fs14 helveticaRoman listContentThird">
                                                    <li class="listSecondItem1" >
                                                    EE reports grants from National Institutes of Health, during the conduct of the study;<br/>
                                                    personal fees from ViiV Healthcare, outside the submitted work
                                                    </li>
                                                    <li class="listSecondItem2">
                                                        <span class="listSecondItem">
                                                    BV reports personal fees from AbbVie, personal fees from Janssen, grants from Takeda,<br/>
                                                    Roche, Celgene, Diasorin, outside the submitted work</span>
                                                    </li>
                                                    <li class="listSecondItem3"><span class="listThirdItem">
                                                            AK and RR report no conflicts of interest
                                                    </span>
                                                    
                                                    </li>
                                                </ul>
                                            </div>
        
                                    </div>
                                
                            </div>
                            <div class="footerNote fs14 helveticaRoman">
                                    Provided pursuant to FDAMA  &sect; <span class="footerNumber">114.</span> 
                            </div>
                        </section>
                        <!-- Slide Specific Code End -->
                        
                        <!-- SmartBalance Headline Start -->
                        <div class="ssiTxt">
                            Important Safety Information
                        </div>
                        <!-- SmartBalance Headline End -->
                        
                        <!-- SmartBalance Content starts -->
                        <section id="smartBalance">&nbsp;</section>
                        <!-- SmartBalance Content ends -->
                    </div>
                    <!-- Landscape End -->
                   
    			</div> <!--======== main content Ends ===========-->
    		</section><!--//contentWrapper-->

    		<footer data-count="six">&nbsp;</footer>
    	</section><!--//wrapper-->

    	<!-- ================= Global popups Start=====================-->
        <section id="globalComponent">&nbsp;</section>
    	<!-- ================= Global popups End=====================-->
       
        <script src="../shared/shared-dificid-v4/js/jquery-2.2.3.min.js" charset="utf-8"></script>
        <script src="../shared/shared-dificid-v4/shared-main.js" charset="utf-8"></script>
    </body>
</html>